| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226720 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 5 Pages |
Abstract
Captopril therapy produces no detectable adverse effects when given after TBI. Captopril therapy reduces overall and pulmonary-related mortality after radiation-based HSCT, and there is a trend toward mitigation of chronic renal failure.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eric P. M.D., Manpreet M.D., Amy A. B.S., Elizabeth M.D., Rade M.D., John Ph.D., Colleen A. M.D., FASTRO, John E. Ph.D., FASTRO,